The purpose of this study is to determine of clarithromycin effect on developing of bronchopulmonary dysplasia in preterm babies.
The investigators planned that clarithromycin treatment in preterm babies who are under 1250 grams birth weight. The investigators aimed with this treatment, the bronchopulmonary dysplasia rate of preterm babies may decrease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
250
Zekai Tahir Burak Maternity Teaching Hospital
Ankara, Middle Anatolia, Turkey (Türkiye)
RECRUITINGBronchopulmonary dysplasia
On the 28. day of birth, The investigator will determine the baby whether has developed bronchopulmonary dysplasia
Time frame: 28. day of birth
Overall survival
During to hospitalisation the investigator will determine and record some co-morbidities of BPD such as intracranial hemorrhage, necrotizing enterocolitis, patent ductus arteriosus rates.From date of randomization until the end of the hospitalisation up to the 3 months of life.
Time frame: Participants will be followed for the duration of hospital stay, an expected average of postnatal 40 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.